Antares Pharma to Participate at the Morgan Stanley Healthcare Conference
Antares Pharma, Inc. today announced that Eamonn P. Hobbs, President and Chief Executive Officer and Robert F. Apple, Chief Financial ...
Antares Pharma, Inc. today announced that Eamonn P. Hobbs, President and Chief Executive Officer and Robert F. Apple, Chief Financial ...
The board of directors of Luye Pharma Group Ltd., announced yesterday that the Company had entered into an agreement to ...
The board of directors of Luye Pharma Group Ltd., announced yesterday that the Company had entered into an agreement to ...
The US Food and Drug Administration (FDA) has lifted a partial hold on patient enrolments for three Phase Ib clinical ...
Denmark-based Novo Nordisk has introduced Ryzodeg (insulin degludec/insulin aspart) in Mexico, which will be used to treat adult patients suffering ...
Boston Strategics (BSC) has started a Phase I clinical trial of Fujifilm's anti-cancer agent FF-10501 in the US to treat ...
US-based biopharmaceutical firm Exelixis has reported disappointing top-line results from the final analysis of COMET-1, the Phase III trial of ...
InnoPharma, Inc. today announced the approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application ...
US-based biotech firm Senesco Technologies has completed patient enrolment in its ongoing Phase Ib/IIa clinical trial of SNS01-T to treat ...
The US Food and Drug Administration (FDA) has granted clearance to Asterias Biotherapeutics for the initiation of a Phase I/IIa ...
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.